Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribonucleotide reductase subunit R1 is a critical component of ribonucleotide reductase (RNR), an essential enzyme responsible for the de novo synthesis of deoxyribonucleotides from ribonucleotides. This reaction provides the building blocks required for DNA synthesis and repair, making RNR indispensable for cell proliferation and survival. It catalyzes the reduction of ribonucleoside diphosphates (NDPs) to their corresponding deoxyribonucleoside diphosphates (dNDPs), which are then further phosphorylated to form dNTPs, the direct precursors for DNA synthesis. Plays a key regulatory role in maintaining balanced dNTP pools within cells, ensuring high fidelity during DNA replication and repair processes. The activity of RNR is tightly regulated throughout the cell cycle to match cellular demands for DNA synthesis. Overexpression or dysregulation is associated with cancer progression. It serves as an established target for anticancer drugs such as hydroxyurea and gemcitabine that inhibit its function directly or indirectly.
Inhibition of ribonucleotide reductase activity, leading to depletion of dNTPs and inhibition of DNA synthesis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribonucleotide reductase subunit R1 (None).